| Early on‐treatment prediction of response to peginterferon alfa‐2a for HBeAg‐negative chronic hepatitis B using HBsAg and HBV DNA levels V Rijckborst, BE Hansen, Y Cakaloglu, P Ferenci, F Tabak, M Akdogan, ... Hepatology 52 (2), 454-461, 2010 | 339 | 2010 |
| A randomized trial of peginterferon α-2a with or without ribavirin for HBeAg-negative chronic hepatitis B V Rijckborst, MJ Ter Borg, Y Cakaloglu, P Ferenci, F Tabak, M Akdogan, ... The American journal of gastroenterology 105 (8), 1762, 2010 | 105 | 2010 |
| Cytokine mRNA expression in hepatitis C virus infection: TH1 predominance in patients with chronic hepatitis C and TH1–TH2 cytokine profile in subjects with self‐limited disease E Gigi, M Raptopoulou‐Gigi, A Kalogeridis, S Masiou, E Orphanou, ... Journal of viral hepatitis 15 (2), 145-154, 2008 | 75 | 2008 |
| Analysis of hepatitis B genotype changes in chronic hepatitis B infection: Influence of antiviral therapy R Jardi, F Rodriguez-Frias, M Schaper, E Giggi, D Tabernero, M Homs, ... Journal of hepatology 49 (5), 695-701, 2008 | 64 | 2008 |
| Anaphylactic and anaphylactoid reactions during the perioperative period V Lagopoulos, E Gigi Hippokratia 15 (2), 138, 2011 | 56 | 2011 |
| Long term follow-up of a large cohort of inactive HBsAg (+)/HBeAg (-)/anti-HBe (+) carriers in Greece E Gigi, T Lalla, E Orphanou, E Sinakos, E Vrettou, M Raptopoulou-Gigi JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES 16 (1), 19, 2007 | 50 | 2007 |
| The role of capsule endoscopy in the evaluation and treatment of obscure-overt gastrointestinal bleeding during daily clinical practice: a prospective multicenter study P Katsinelos, G Lazaraki, A Gkagkalis, A Gatopoulou, S Patsavela, ... Scandinavian journal of gastroenterology 49 (7), 862-870, 2014 | 36 | 2014 |
| Hepatitis B reactivation in a patient with rheumatoid arthritis with antibodies to hepatitis B surface antigen treated with rituximab E Gigi, T Georgiou, D Mougiou, P Boura, M Raptopoulou-Gigi Hippokratia 17 (1), 91, 2013 | 36 | 2013 |
| Health-related quality of life in Greek chronic hepatitis C patients during pegylated interferon and ribavirin treatment E Sinakos, E Gigi, T Lalla, AL Bellou, A Sykja, E Orphanou, E Vrettou, ... Hippokratia 14 (2), 122, 2010 | 31 | 2010 |
| Epidemiology, clinical data, and treatment of viral hepatitis in a large cohort of intravenous drug users E Gigi, E Sinakos, A Sykja, G Androulakis, C Tanis, V Stayridou, ... Journal of addiction medicine 7 (1), 52-57, 2013 | 25 | 2013 |
| Treatment of intravenous drug users with chronic hepatitis C: treatment response, compliance and side effects E Gigi, E Sinakos, TH Lalla, E Vrettou, E Orphanou, M Raptopoulou Hippokratia 11 (4), 196, 2007 | 25 | 2007 |
| Hepatitis C virus survival curve analysis in naive patients treated with peginterferon alpha-2b plus ribavirin. A randomized controlled trial for induction with high doses of … K Mimidis, VP Papadopoulos, I Elefsiniotis, D Koliouskas, I Ketikoglou, ... JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES 15 (3), 213, 2006 | 24 | 2006 |
| Severe autoimmune hemolytic anemia complicated with liver decompensation and invasive aspergillosis in a patient with chronic hepatitis C during treatment with peg-interferon-a … A Sykia J Gastrointestin Liver Dis 18, 118-119, 2009 | 17 | 2009 |
| Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review E Gigi, VI Lagopoulos, E Bekiari World Journal of Hepatology 10 (9), 595-602, 2018 | 16 | 2018 |
| Deferasirox improves liver fibrosis in beta‐thalassaemia major patients. A five‐year longitudinal study from a single thalassaemia centre N Sousos, E Sinakos, P Klonizakis, D Adamidou, A Daniilidis, E Gigi, ... British journal of haematology 181 (1), 140-142, 2018 | 8 | 2018 |
| Vitamin B12 Deficiency and Hemoglobin H Disease Early Misdiagnosed as Thrombotic Thrombocytopenic Purpura: A Series of Unfortunate Events P Andreadis, S Theodoridou, M Pasakiotou, S Arapoglou, E Gigi, ... Case reports in hematology 2015, 2015 | 6 | 2015 |
| Virologic response and resistance to lamivudine in patients with chronic hepatitis B: a ten-year retrospective analysis E Gigi, A Sykia, E Sinakos, G Koumerkeridis, M Raptopoulou-Gigi, ... Hippokratia 16 (4), 342, 2012 | 3 | 2012 |
| 270 CD4+ CD25+ FOXP3+ TREGS: DO THEY INHIBIT HCV CLEARANCE IN CHRONIC HCV GENOTYPE 1 INFECTION? AL Bellou, A Sarantopoulos, E Gigi, A Sykia, A Beltsis, P Boura, ... Journal of Hepatology 54, S111, 2011 | 2 | 2011 |
| 602 Treatment of intravenous drug users (IVDU) with chronic hepatitis C: Treatment response, compliance and side effects M Raptopoulou, T Lalla, E Sinakos, E Gigi, E Vrettou, E Orphanou Journal of Hepatology 44, S223, 2006 | 2 | 2006 |
| HEPATITIS E IN TRANSFUSION-DEPENDENT THALASSEMIA PATIENTS, IN GREECE. A SINGLE CENTER EXPERIENCE P Klonizakis, G Gioula, A Melidou, M Exindari, G Karavalakis, ... HAEMATOLOGICA 102, 866-866, 2017 | | 2017 |
